Annual Report: Program Year 4 October 2014–September 2015

The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services to achieve desired health outcomes. The program’s result areas include improving governance, building capacity for pharmaceutical management and services, addressing information needed for decision-making in the pharmaceutical sector, strengthening financing strategies and mechanisms to improve access to medicines, and increasing quality pharmaceutical services.

SIAPS has been working in multiple countries to strengthen pharmaceutical systems and improve access to essential medicines. In Angola, the program supported the development of a national essential medicine list and provided training to healthcare workers on rational medicine use. In Bangladesh, SIAPS helped establish a national medicines regulatory authority and implemented a system for tracking and monitoring medicines.

In Burundi, the program supported the development of a national pharmaceutical policy and provided training to healthcare workers on pharmaceutical management. In Cameroon, SIAPS helped establish a national medicines regulatory authority and implemented a system for tracking and monitoring medicines. In Central Asia, the program supported the development of a regional essential medicine list and provided training to healthcare workers on rational medicine use.

In the Democratic Republic of the Congo, SIAPS supported the development of a national pharmaceutical policy and provided training to healthcare workers on pharmaceutical management. In the Dominican Republic, the program helped establish a national medicines regulatory authority and implemented a system for tracking and monitoring medicines. In Ethiopia, SIAPS supported the development of a national essential medicine list and provided training to healthcare workers on rational medicine use.

In Guinea, the program supported the development of a national pharmaceutical policy and provided training to healthcare workers on pharmaceutical management. In Haiti, SIAPS helped establish a national medicines regulatory authority and implemented a system for tracking and monitoring medicines. In Lesotho, the program supported the development of a national essential medicine list and provided training to healthcare workers on rational medicine use.

In Mali, SIAPS supported the development of a national pharmaceutical policy and provided training to healthcare workers on pharmaceutical management. In Mozambique, the program helped establish a national medicines regulatory authority and implemented a system for tracking and monitoring medicines. In Namibia, SIAPS supported the development of a national essential medicine list and provided training to healthcare workers on rational medicine use.

In Niger, the program supported the development of a national pharmaceutical policy and provided training to healthcare workers on pharmaceutical management. In the Philippines, SIAPS helped establish a national medicines regulatory authority and implemented a system for tracking and monitoring medicines. In South Africa, the program supported the development of a national essential medicine list and provided training to healthcare workers on rational medicine use.

In South Sudan, SIAPS supported the development of a national pharmaceutical policy and provided training to healthcare workers on pharmaceutical management. In Swaziland, the program helped establish a national medicines regulatory authority and implemented a system for tracking and monitoring medicines. In Ukraine, SIAPS supported the development of a national essential medicine list and provided training to healthcare workers on rational medicine use.

In West Africa, the program supported the development of a regional essential medicine list and provided training to healthcare workers on rational medicine use. The SIAPS program has made significant progress in strengthening pharmaceutical systems and improving access to essential medicines in multiple countries.

Défiler vers le haut